Guerbet (EURONEXT:GBT) - Share price - Overview

Stock Report

Guerbet GBT

Last Price
56.60

Day Change
0.10|0.18%

As of 25/05/2018
17:35:09 CEST | EUR
Minimum 15 Minutes Delay.

Last Close56.50
Day Range56.10 - 57.00
Mkt Cap710.40Mil
52-Wk Range50.00 - 87.65
Yield %1.50
ISINFR0000032526
Volume8,561
P/E15.51
P/S0.89
P/CF12.79

Share Price

Financials
201520162017
More ...
Income Statement
Revenue489.88776.43808.63
Operating Income57.4456.0178.68
Net Income39.9228.9346.22
Basic EPS3.272.333.69
Avg. Diluted Shares Outstanding131313
Balance Sheet
Current Assets503.13621.51558.14
Non Current Assets395.69406.64395.45
Total Assets898.821,028.15953.59
Current Liabilities266.32325.36263.08
Total Liabilities---
Total Equity283.85314.80342.14
Cash Flow
Operating Cash Flow74.3438.6956.05
Capital Expenditure-36.31-49.78-46.49
Free Cash Flow38.03-11.109.56

In millions, except "Basic EPS". Currency is EUR.

Company Profile

Guerbet is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

353
Key Stats
More ...
Price/Earning TTM15.31
Price/Book2.07
Price/Sales TTM0.88
Rev Growth (3 year avg)25.46
EPS Growth (3 year avg)-
Operating Margin % TTM9.73
Net Margin % TTM5.72
ROE TTM14.07
Debt/Equity0.84
Dividends
PreviousLatest
More ...
Declared Date12/04/1728/03/18
Ex-Div25/05/1731/05/18
Paid29/05/1704/06/18
Amnt0.850.85
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.